Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics.

Jürgen B Bulitta, Yuanyuan Jiao, Cornelia B Landersdorfer, Dhruvitkumar S Sutaria, Xun Tao, Eunjeong Shin, Rainer Höhl (Co-author), Ulrike Holzgrabe, Ulrich Stephan, Fritz Sörgel

Research output: Contribution to journalOriginal Articlepeer-review

4 Citations (Web of Science)
Original languageEnglish
JournalPHARMACEUTICS
Volume11
Issue number7
DOIs
Publication statusPublished - 2019

Keywords

  • PHARMACODYNAMIC BREAKPOINTS
  • INTESTINAL ELIMINATION
  • ORAL BIOAVAILABILITY
  • GYRASE INHIBITORS
  • P-GLYCOPROTEIN
  • CIPROFLOXACIN
  • SECRETION
  • INVOLVEMENT
  • MECHANISM
  • PATHWAYS

Cite this